Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients Bempedoic Acid Cuts CV Events in Statin-Intolerant Patients

The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL-lowering therapies, experts say.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Cardiology News Source Type: news